Trial Profile
A multicenter, observational, open-label study of Dasatinib in patients with Chronic Myeloid Leukemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jul 2017
Price :
$35
*
At a glance
- Drugs Dasatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- Acronyms Pcr-Depth
- 25 Jun 2017 Results presented at the 22nd Congress of the European Haematology Association
- 12 Sep 2016 New trial record